Improving the Patient Journey in Drug Development

[Sponsored] PurpleLab and Genentech executives will explore how to leverage real world data to eliminate blind spots in the patient journey — informing every phase of a drug’s lifecycle, from clinical development to market access — in a May 22 webinar. The post Improving the Patient Journey in Drug Development appeared first on MedCity News.

Read More

Bridging Financial Services and Healthcare

By creating payment experiences that feel less like a burden and more like the seamless, convenient, flexible transactions patients experience elsewhere, we can significantly improve both patient satisfaction and financial performance. The post Bridging Financial Services and Healthcare appeared first on MedCity News.

Read More

Trump Strategy to Rein In Drug Prices Revives ‘Most Favored Nation’ Plan of His First Term

President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower prices paid in other countries, what’s called most-favored-nation pricing. If drug companies do not lower their prices accordingly, the order proposes other strategies, such as importing drugs from other countries. The post Trump Strategy to Rein In…

Read More

Details From Head-to-Head Phase 3 Test Give Fuller Picture of Zepbound’s Edge Over Wegovy

Eli Lilly reported that in addition to achieving greater reductions in weight, Zepbound-treated patients achieved greater reductions in waist circumference compared to those treated with Novo Nordisk’s Wegovy. Full details from the head-to-head Phase 3 test were presented at the European Congress on Obesity meeting. The post Details From Head-to-Head Phase 3 Test Give Fuller…

Read More